Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes.
- DOI
- 10.1016/j.diabres.2026.113474
- Published
- 2026-08-02
- Container
- Diabetes Res Clin Pract
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.diabres.2026.113474,
title = {Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes.},
author = {Luo Y and Xia J and Yao X and Jahed SA and Bee YM and Chen L and Chan SP and Deerochanawong C and Shan Kong AP and Nguyen KT and Li X and Lim S and Loganadan NK and McGill M and Trejo SE and Yabe D and Yan L and Li P and Zhao Z and Chen S and Cheng AYY and Ji L and Chinese Association of Geriatric Research.},
year = {2026},
journal = {Diabetes Res Clin Pract},
doi = {10.1016/j.diabres.2026.113474},
url = {https://doi.org/10.1016/j.diabres.2026.113474}
}RIS
TY - JOUR TI - Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes. AU - Luo Y AU - Xia J AU - Yao X AU - Jahed SA AU - Bee YM AU - Chen L AU - Chan SP AU - Deerochanawong C AU - Shan Kong AP AU - Nguyen KT AU - Li X AU - Lim S AU - Loganadan NK AU - McGill M AU - Trejo SE AU - Yabe D AU - Yan L AU - Li P AU - Zhao Z AU - Chen S AU - Cheng AYY AU - Ji L AU - Chinese Association of Geriatric Research. PY - 2026 JO - Diabetes Res Clin Pract DO - 10.1016/j.diabres.2026.113474 UR - https://doi.org/10.1016/j.diabres.2026.113474 ER -
APA
Y, L., J, X., X, Y., SA, J., YM, B., L, C., SP, C., C, D., AP, S. K., KT, N., X, L., S, L., NK, L., M, M., SE, T., D, Y., L, Y., P, L., Z, Z., S, C., AYY, C., L, J., & Research., C. A. O. G. (2026). Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes.. Diabetes Res Clin Pract. https://doi.org/10.1016/j.diabres.2026.113474
Source records
- europe-pmc · retrieved 2026-09-26T12:34:23.690Z